Ms Susan Robinson, MS in Washington, DC - Speech-Language Pathologist

Ms Susan Robinson, MS is a Speech-language Pathologist based in Washington, District Of Columbia. Ms Susan Robinson is licensed to practice in * (Not Available) (license number ) and her current practice location is 1200 1st St Ne Fl 9, Washington, District Of Columbia. She can be reached at her office (for appointments etc.) via phone at (202) 724-4800.

NPI number for Ms Susan Robinson is 1225467905 and her current mailing address is 1200 1st St Ne Fl 9, Washington, District Of Columbia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1225467905.

Contact Information

	Ms Susan Robinson, MS
	1200 1st St Ne Fl 9, Washington, DC 20002-7953
	(202) 724-4800
	Not Available

Healthcare Provider's Profile

Full Name	Ms Susan Robinson
Gender	Female
Speciality	Speech-language Pathologist
Location	1200 1st St Ne Fl 9, Washington, District Of Columbia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1225467905
Provider Enumeration Date: 11/04/2013
Last Update Date: 11/04/2013

Medical Identifiers

Medical identifiers for Ms Susan Robinson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1225467905	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Susan Robinson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Susan Robinson, MS 1200 1st St Ne Fl 9, Washington, DC 20002-7953 Ph: () -	Ms Susan Robinson, MS 1200 1st St Ne Fl 9, Washington, DC 20002-7953 Ph: (202) 724-4800

News Archive

Study finds a significant link between statins and survival rates of triple-negative breast cancer patients

A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an important impact on outcomes for this aggressive disease.

EMA acceptance of brentuximab vedotin MAA triggers $5M milestone payment to Seattle Genetics

Seattle Genetics, Inc., today announced that it will receive a $5 million milestone payment under its brentuximab vedotin (ADCETRIS) collaboration with Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

Novel computer algorithm can easily quantify major risk factor for breast cancer

Researchers at Moffitt Cancer Center and colleagues at the Mayo Clinic in Rochester, Minn., have developed a novel computer algorithm to easily quantify a major risk factor for breast cancer based on analysis of a screening mammogram. Increased levels of mammographic breast density have been shown in multiple studies to be correlated with elevated risk of breast cancer, but the approach to quantifying it has been limited to the laboratory setting where measurement requires highly skilled technicians.

DMS receives NIH grant to establish Center of Biomedical Research Excellence

Under an $11-million grant from the National Institutes of Health (NIH), Dartmouth Medical School (DMS) will lead a network of northern New England institutions in recruiting, training, and supporting young quantitative biologists to teach and conduct research into the ways that genes and the environment work together to trigger and prevent disease.

Ebola more likely to be fatal for young children

Ebola progresses more quickly and is more likely to be fatal for children under five, according to new research. An international group of scientists led by Imperial College London and the World Health Organization analysed data on Ebola cases in children under 16 during the current outbreak in Guinea, Liberia and Sierra Leone, comparing them to cases in adults.

Speech-Language Pathologist in Washington, DC

Sheryl Jacob Desbordes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-4424
Karen Garrido-nag, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Speech, Language And Hearing Sciences, Washington, DC 20002 Phone: 202-448-6964 Fax: 202-448-5324
Voicetrainer, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Pennsylvania Ave Nw, Suite 300, Washington, DC 20006 Phone: 202-580-6646 Fax: 202-580-6559
Samantha Wasilus, M.S CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4880 Macarthur Blvd Nw, Washington, DC 20007 Phone: 202-333-1403 Fax: 202-333-1404
Tahera Sparks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Connecticut Ave Nw # 100, Washington, DC 20008 Phone: 202-525-1641
Sydney Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Massachusetts Ave Ne Ste C9, Washington, DC 20002 Phone: 202-544-5469
Joyce Doyle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3009 5th St Se, Washington, DC 20032 Phone: 571-221-2840

Ms Susan Robinson, MS - Speech-Language Pathologist in Washington, DC